Literature DB >> 32631428

The treatments and postoperative complications of esophageal cancer: a review.

Qi-Liang Xu1, Hua Li2, Ye-Jing Zhu3, Geng Xu4.   

Abstract

Esophageal cancer is still one of the most common cancers in the world. We review the appropriate treatments at different stages of esophageal cancer and also analyze the advantages and disadvantages of these treatments. The prognosis and recovery of different treatment regimens are further discussed. In particular, post-operative complications are the major causes of high mortality derived from the esophageal cancer. Therefore, we particularly discuss the main complications resulting in high mortality after surgery of esophageal cancer, and summarize their risk factors and treatment options.
BACKGROUND: As the common cancer, the complications of esophageal cancer after surgery have been not obtained systematic treatment strategy, focusing on treatment regimens based on the different stages of esophageal cancers. METHODS AND OVERVIEW: This paper systematically summarizes the appropriate treatment strategies for different stages of esophageal cancers, and their advantages and disadvantages. We particularly focus on the postoperative survival rate of patients and postoperative complications, and discuss the causes of high mortality risk factors after surgery. The risk factors of death and corresponding treatment methods are further summarized in this study.
CONCLUSION: Postoperative complications is the main cause responsible for the hard cure of esophageal cancers. The existing literatures indicate that postoperative anastomotic fistula is one of the most important complications leading to death, while it has not received much attention yet. We suggest that anastomotic fistula should be detected and dealt with early by summarizing these literatures. It is, therefore, necessary to develop a set of methods to predict or check anastomotic fistula in advance.

Entities:  

Keywords:  Anastomotic fistula; Diagnosis; Esophageal cancer; Postoperative complications; Risk factors

Year:  2020        PMID: 32631428     DOI: 10.1186/s13019-020-01202-2

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  10 in total

1.  Protective Effect of Targeted Fluid Therapy on Patients with One-Lung Ventilation.

Authors:  Ji-Bo Zhao; Yuan-Li Li; Deng-Yun Xia; Xiao-Jia Sun; Fu-Long Li; Zhen Xing
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-06       Impact factor: 2.650

2.  circRNA TCFL5 Promote Esophageal Cancer Progression by Modulating M2 Macrophage Polarization via the miR-543-FMNL2 Axis.

Authors:  Chengbin Lin; Yong Xi; Hongyan Yu; Zheng Wang; Xiaohan Chen; Weiyu Shen
Journal:  J Oncol       Date:  2022-05-18       Impact factor: 4.501

3.  Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.

Authors:  Ji Feng Feng; Liang Wang; Qi-Xun Chen; Xun Yang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

4.  Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma.

Authors:  Can Luo; Xin Chen; Yuting Bai; Lei Xu; Shuqi Wang; Lihua Yao; Xiaolan Guo; Dongsheng Wang; Xiaowu Zhong
Journal:  Int J Genomics       Date:  2022-03-20       Impact factor: 2.326

5.  Impact of body mass index on perioperative and oncological outcomes in elderly patients undergoing minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma.

Authors:  Chaoyang Tong; Huijie Lu; Hongwei Zhu; Jingxiang Wu
Journal:  Cancer Med       Date:  2022-03-21       Impact factor: 4.711

6.  Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.

Authors:  Jun Hou; Yinfeng Yang; Honglei Gao; Ting Ouyang; Qiwei Liu; Ran Ding; Hongxing Kan
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

7.  Successful management of therapy-refractory pseudoachalasia after Ivor Lewis esophagectomy by bypassing colonic pull-up: A case report.

Authors:  Sven Flemming; Johan F Lock; Mohammed Hankir; Stanislaus Reimer; Bernhard Petritsch; Christoph-Thomas Germer; Florian Seyfried
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

8.  From open Ivor Lewis esophagectomy to a hybrid robotic-assisted thoracoscopic approach: a single-center experience over two decades.

Authors:  Fiorenzo V Angehrn; Kerstin J Neuschütz; Lana Fourie; Alexander Wilhelm; Silvio Däster; Christoph Ackermann; Markus von Flüe; Daniel C Steinemann; Martin Bolli
Journal:  Langenbecks Arch Surg       Date:  2022-03-24       Impact factor: 2.895

9.  Psychological impact of high-quality nursing care on patients with esophageal cancer during perioperative period: A protocol of systematic review.

Authors:  Xiu-Yu Liu; Chuan-Hua Jiao; Dan Zhao; Yan Chen; Hong-Mei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

10.  Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.

Authors:  Yuhua Chen; Jinjie Wang; Hao Zhou; Zhanghao Huang; Li Qian; Wei Shi
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.